Balyasny Asset Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
Balyasny Asset Management's PRCT Position: Q3 2026 in Review
Balyasny Asset Management increased its Procept Biorobotics (PRCT) stake by 3,619% in Q3 2026, buying an estimated $20.3M and bringing the position to 1,048,790 shares worth $19.1M. The position accounts for 0.02% of the portfolio, ranked #790.
Balyasny Asset Management first reported a position in PRCT in Q3 2021 and has held it in 6 quarters since. 232 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- Balyasny Asset Management held 1,048,790 shares of Procept Biorobotics worth $19.1M as of Q3 2026.
- Balyasny Asset Management bought 1,020,589 Procept Biorobotics shares in Q3 2026, an estimated $20.3M.
- Procept Biorobotics made up 0.02% of Balyasny Asset Management's portfolio in Q3 2026, its #790 holding.
- Balyasny Asset Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 6 quarters since.
- 232 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.